CONMED Corporation Sustainability Profile
CONMED Corporation, a leading player in the medical technology industry, is headquartered in the United States. Founded in 1970, the company has established a strong presence in various operational regions, including North America, Europe, and Asia. Specialising in surgical and patient monitoring products, CONMED is renowned for its innovative solutions in areas such as orthopaedics, general surgery, and endoscopy. The company’s core offerings include advanced surgical instruments, electrosurgical devices, and video imaging systems, all designed to enhance surgical precision and patient outcomes. Notably, CONMED has achieved significant milestones, including the development of cutting-edge technologies that set industry standards. With a commitment to quality and innovation, CONMED Corporation continues to solidify its market position as a trusted provider of medical devices, making a meaningful impact in healthcare worldwide.
DitchCarbon Score
How does CONMED Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
CONMED Corporation's score of 19 is lower than 82% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
CONMED Corporation's reported carbon emissions
In 2024, CONMED Corporation reported total carbon emissions of approximately 1,103,900 kg CO2e. This figure includes 142,140 kg CO2e from Scope 1 emissions, 9,270 kg CO2e from Scope 2 emissions, and a significant 952,490 kg CO2e from Scope 3 emissions. The Scope 3 emissions represent the largest portion of their carbon footprint, highlighting the importance of addressing indirect emissions in their climate strategy. In comparison, the previous year, 2023, CONMED's Scope 3 emissions were approximately 912,400 kg CO2e, indicating an increase in this category. However, specific reduction targets or initiatives have not been disclosed, and there are no reported commitments to the Science Based Targets initiative (SBTi) or other climate pledges. CONMED's emissions data is not cascaded from any parent organisation, indicating that these figures are independently reported. The company is actively working on its carbon reduction plan, although detailed targets and achievements remain unspecified. As a leader in the medical technology industry, CONMED's commitment to addressing its carbon emissions is crucial for aligning with global climate goals.
How Carbon Intensive is CONMED Corporation's Industry?
How Carbon Intensive is CONMED Corporation's Location?
CONMED Corporation's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
CONMED Corporation has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
